Publication details
Výzkum léků v Čechách. Příležitost pro pacienty, lékaře i české zdravotnictví
| Title in English | Drug research in the Czech Republic. An opportunity for patients, doctors, and the Czech healthcare system |
|---|---|
| Authors | |
| Year of publication | 2022 |
| Type | Conference |
| MU Faculty or unit | |
| Citation | |
| Description | More than 396 clinical trials of new drugs are underway in the Czech Republic, especially in oncology, infectious diseases, and nervous system diseases. Over 16,000 patients and almost 2,000 medical teams were involved in the evaluation last year. The total costs of pharmaceutical companies for evaluating new drugs exceeded 2.5 billion crowns. As part of the press conference, together with doctors, participants in the evaluation, patients, and representatives of the pharmaceutical industry, we will talk about what, from their point of view, is the benefit of the development of new drugs and why it is important not to slack off in it. |